Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09VRZ
|
|||
| Former ID |
DIB012549
|
|||
| Drug Name |
AZM-131
|
|||
| Indication | Obesity [ICD-11: 5B81; ICD-10: E66; ICD-9: 278] | Terminated | [1] | |
| Company |
Alizyme plc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Pancreatic triacylglycerol lipase (PNLIP) | Target Info | Modulator | [2] |
| BioCyc | Triacylglycerol degradation | |||
| Retinol biosynthesis | ||||
| KEGG Pathway | Glycerolipid metabolism | |||
| Metabolic pathways | ||||
| Pancreatic secretion | ||||
| Fat digestion and absorption | ||||
| Vitamin digestion and absorption | ||||
| Reactome | Retinoid metabolism and transport | |||
| WikiPathways | Visual phototransduction | |||
| Lipid digestion, mobilization, and transport | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008694) | |||
| REF 2 | US patent application no. 7217,697, Glucopyranosyloxypyrazole derivative medicinal composition containing the same medicinal use thereof and intermediate therefor. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.